[Diagnostics and treatment of differentiated thyroid cancer using nuclear medicine].
Differentiated thyroid cancer (DTC) is a rare cancer with excellent prognosis for most patients. Primary treatment is surgery. Adjuvant radioiodine is used after surgery and in case of residual radioiodine positive disease. Measurements of serum thyroglobulin levels and neck ultrasound (US) are the primary follow-up procedures. For suspected recurrence, US, computed tomography (CT), radioiodine single photon emission computed tomography/CT, and FDG positron emission tomography/CT will be appropriate choices for restaging and further treatment planning. Multidisciplinary collaboration is crucial for optimal management of patients with DTC.
Nuklearmedicinsk Afdeling & PET-Center, Aarhus Universitetshospital, Nørrebrogade 44, 8000 Aarhus C, Denmark. anni.morsing@aarhus.rm.dk
Anni
A
Morsing
Trond Velde
TV
Bogsrud
D001323:Autoantibodies / Q000097:blood; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D064847:Multimodal Imaging / Q000379:methods*; D009683:Nuclear Medicine; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D013954:Thyroglobulin / Q000032:analysis; D013961:Thyroid Gland / Q000000981:diagnostic imaging / Q000378:metabolism; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging / Q000628:therapy; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography
D001323:Autoantibodies; D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D013954:Thyroglobulin